Archive for February, 2019

The EU Orphan Regulation: A success story in driving R&D of orphan medicines in the EU – but what about access?

Posted by:

Pugatch Consilium is today releasing a new study – Benchmarking Success: Evaluating the Orphan Regulation and its impact on patients and rare disease R&D in the European Union.

Within the context of the European Commission’s Evaluation of the legislation on medicines for children and rare diseases, the study examines whether the EU Orphan Regulation has accomplished its aim of incentivising the development and introduction of new therapies for rare diseases onto the EU market, and explores some of the current and ...

Continue Reading →
0